# DTMO Executive Decision View

## Purpose

This document gives accountable decision makers a concise view of what is accepted, what remains outstanding and what evidence is required before DTMO may be considered production ready.

## Current position

| Decision area | Current state | Decision consequence |
|---|---|---|
| Repository-controlled engineering | `PASS` for Phases 1–7 | Engineering foundation accepted within repository boundary |
| Functional product | `RC13 PASS / OWNER_ACCEPTED` | Canonical product journey accepted |
| E8 vulnerability/CTI product line | `PASS / REPOSITORY_COMPLETE` | Product capabilities repository-complete |
| Post-E8 staging deployment | `PASS / OWNER_VERIFIED_EXTERNAL_EVIDENCE` | Approved production-equivalent staging exists and was owner-tested |
| Phase 8.2–8.4 | `CONTRACT COMPLETE / EXTERNAL ACCEPTANCE REQUIRED` | External validation evidence remains to be accepted |
| Phase 8.5 | `CONTRACT COMPLETE / EXTERNAL OWNER DECISION REQUIRED` | Phase 8 is not yet formally closed |
| Phase 9 independent assurance | `NOT COMPLETE` | External assurance remains mandatory |
| Phase 10 production authorization | `NOT STARTED` | No production approval may be inferred |

## Decision interpretation

DTMO has a mature repository-controlled product baseline and an approved staging deployment. That does **not** yet equal production readiness. The decisive remaining Phase 8 task is to consolidate and accept the external validation evidence against one immutable deployment identity.

The current state demonstrates product and engineering maturity. It does not yet establish independent attack resistance, independently reviewed hardening, accepted residual risk or formal production authorization.

## Required progression

### 1. Close Phase 8

Bind all Phase 8 evidence to one immutable post-E8 staging identity, including the exact deployed release/commit, immutable image digests, runtime/configuration evidence and accepted platform, source-to-intelligence and operations/recovery results. Record deviations, residual risks, release-blocking findings and the accountable Phase 8.5 decision.

### 2. Complete Phase 9

Execute independent penetration testing and the agreed external hardening, IAM/secrets, load/stress, resilience/recovery, monitoring/incident-response and relevant privacy/legal/governance assurance. Findings must be triaged, remediated/retested where release-blocking, or formally dispositioned by accountable risk ownership.

### 3. Decide Phase 10

Only after Phase 8 and Phase 9 are accepted may accountable stakeholders decide production go/no-go.

## Decision rules

- Green CI is not external staging acceptance.
- Functional owner acceptance is not independent assurance.
- Approved staging is not production authorization.
- A framework mapping is not a blanket compliance or maturity claim.
- Technical administration or connector capability does not grant publication/share authority.
- Missing or inaccessible evidence is not implicit acceptance.
- Historical evidence remains valid only for the state/deployment it actually covered.

## Principal decision inputs

Decision makers should use, in order:

1. `CURRENT_STATE.md`;
2. `PRODUCTION_READINESS_REPORT.md`;
3. `PRODUCTION_CHECKLIST.md`;
4. `../roadmap/PRODUCTION_ROADMAP.md`;
5. `../evidence/EVIDENCE_INDEX.md`;
6. `../security/SECURITY_OVERVIEW.md`;
7. `../operations/OPERATING_MODEL.md`;
8. the Phase 8.5 acceptance package;
9. `../qa/PHASE9_EXTERNAL_ASSURANCE_GATE.md` and resulting independent assurance package.

## Current decision

**Do not designate DTMO production ready.** Complete and accept Phase 8 external evidence first, then perform independent Phase 9 assurance. Production authorization remains a separate Phase 10 decision.
